OpenNashPodcasts

Person

Elaine Chen

1 episodes · 4 quoted claims

Elaine Chen reported that one doctor, funded by a Novo Nordisk grant, is tailoring and integrating obesity curricula with 10 medical schools.

“there's one doctor who, you know, through a grant from Novo is working to actually tailor and integrate the curricula with 10 medical schools.”

The Readout Loud (STAT) · 0:29:16

Elaine Chen said side effects of the new obesity drugs so far appear manageable, mainly early nausea and diarrhea, with some concern about rare pancreatitis.

“So far, the side effects seem relatively okay. There's nausea, diarrhea at the beginning. There's concern about maybe potentially rare cases of pancreatitis.”

The Readout Loud (STAT) · 0:32:38

Elaine Chen said there is concern that older people on these drugs could lose lean muscle mass too quickly and become frail.

“there's some concern that they could lose lean mass too quickly, which could lead to them becoming more frail”

The Readout Loud (STAT) · 0:32:38

Data show reduced cardiovascular events in diabetes patients taking these drugs, but not yet in people with obesity alone, according to Elaine Chen.

“for patients with diabetes taking them, there is a reduced risk of cardiovascular events. But we don't yet have data on cardiovascular events for people just with obesity.”

The Readout Loud (STAT) · 0:34:34